Thailand Bioinformatics Market Analysis Report [2022-30] I Insights10

Thailand Bioinformatics Market Analysis

$ 3999

The Thailand Bioinformatics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be technological advancements, growth in the healthcare industry, government support, and private investments. The market is segmented by technology and by application. Some of the major players include Bangkok Genomics Innovation (THA), Agilent Technologies, IBM Life Sciences, Qiagen, and ThermoFisher Scientific.

ID: IN10THHS001 CATEGORY: Healthcare Services GEOGRAPHY: Thailand AUTHOR: Neha Davda

Buy Now

Thailand Bioinformatics Market Executive Summary

The Thailand Bioinformatics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. In 2019, national healthcare spending in Thailand as a percentage of GDP reached 3.79% achieving $296 per capita. Thailand is regarded as one of the most competitive locations in the world for receiving high-quality healthcare at a cheap price. The cost of healthcare in Thailand is roughly one-fifth that in the United States and Europe.

Bioinformatics is a field of research that combines biology and information technology. The techniques utilised in bioinformatics include data production, data warehousing, data mining, data management, and others. For applications like next-generation sequencing, modelling of genomic and proteomic structure, and three-dimensional drug discovery, bioinformatics software and tools are employed as integrated solutions to provide statistical approaches and data processing algorithms. The Asia Pacific region's bioinformatics market is growing swiftly as a result of rising demand for personalised medicine and investments from both the public and private sectors.

Market Dynamics

Market Growth Drivers

The Thailand bioinformatics market is expected to be driven by factors such as technological advancements, growth in healthcare industry and government support. Moreover, the biotechnology and pharmaceutical industries' private investments fuel the Thailand bioinformatics market. Thailand has a large biotechnology and pharmaceutical industry that is primarily reliant on bioinformatics for research and development of novel medications and treatments. These businesses outsource more and more bioinformatics work to firms.

Market Restraints

The field of bioinformatics is a relatively new and complex field and there may be a lack of awareness among researchers and companies in Thailand. Further, the lack of standardization and a limited number of specialised bioinformatics companies in the market also limits the growth of bioinformatics.

Competitive Landscape

Key Players

Bangkok Genomics Innovation (THA)
Agilent Technologies
IBM Life Sciences
Qiagen
ThermoFisher Scientific

Healthcare Policies and Regulatory Landscape

The government's emphasis on building the nation's healthcare infrastructure and encouraging biotechnology research and development has impacted the healthcare policies and regulatory environment for the bioinformatics sector in Thailand. The National Science and Technology Development Agency (NSTDA) and the Thailand Biotechnology Center (TBC) are two of the government's agencies and programmes that can help the bioinformatics sector flourish.

The Ministry of Public Health establishes rules and recommendations for the use of bioinformatics in the healthcare system. The Food and Drug Administration (FDA) is in charge of regulating the safety and efficacy of medical products, including bioinformatics software and services.

Reimbursement Scenario

The National Health Security Office (NHSO), which is in charge of overseeing the nation's universal health coverage (UHC) programme, sets the reimbursement policies in Thailand. For medical services, procedures, and prescription medications that are covered by the UHC programme, the NHSO establishes payment rates.

The Ministry of Public Health has created a list of essential medications that is used to determine drug reimbursement. Based on the cost and efficacy of the medications, the NHSO determines the reimbursement rates for those on the list. The kind of healthcare facility and the services offered also affect the reimbursement policies. For instance, patients treated in hospitals may receive higher reimbursement rates for treatments and procedures than those treated in clinics.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.